title: Insulin resistance and autonomic function in traumatic lower limb amputees.
abstract: This study examined plasma insulin response to oral glucose load and autonomic nervous system activity in male lower limb amputees (n = 52) aged 50-65 years, compared to matched controls (n = 53). The groups had similar body mass index, blood pressure and plasma lipid levels. The amputees had higher mean fasting plasma insulin levels (18.4 +/- 9.7 (SD) versus 13.7 +/- 5.1 mU/l, p = 0.005) and during an oral glucose tolerance test (OGTT) (1 h levels 88.1 +/- 45.3 versus 62.1 +/- 42.7, p = 0.016) with similar plasma glucose levels, indicating insulin resistance. At baseline with the subjects supine, there were no group differences in low- or high-frequency power of heart rate variability or in plasma levels of norepinephrine (NE) or epinephrine (EPI). In response to orthostasis, the groups had similarly increased plasma NE levels. During the OGTT, amputees had significantly larger increments in low-frequency power than did controls (2.2 +/- 1.3 versus 1.6 +/- 0.9 (beats/min)2 respectively, p < 0.01) and plasma NE levels increased significantly in amputees (1595 +/- 849 versus 1941 +/- 986 pM, p = 0.0008) but not in controls. At 1 h after glucose administration, plasma EPI levels were decreased significantly from baseline in both groups; at both 1 and 2 h after glucose administration, plasma EPI levels were higher in the amputees than controls. Amputees appear to have a combination of enhanced sympathoneural responsiveness and attenuated suppression of adrenomedullary secretion during glucose challenge. As catecholamines antagonize insulin effects, one possible explanation for insulin resistance in amputees is hyperglycaemia-induced sympathoneural activation and a failure of hyperglycaemia to decrease adrenomedullary secretion.
authors.affiliation: Department of Clinical Epidemiology, Sheba Medical Centre, Tel Hashomer, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Peles
authors.forename: S
authors.initials: S
authors.lastname: Akselrod
authors.forename: D S
authors.initials: DS
authors.lastname: Goldstein
authors.forename: H
authors.initials: H
authors.lastname: Nitzan
authors.forename: M
authors.initials: M
authors.lastname: Azaria
authors.forename: S
authors.initials: S
authors.lastname: Almog
authors.forename: D
authors.initials: D
authors.lastname: Dolphin
authors.forename: H
authors.initials: H
authors.lastname: Halkin
authors.forename: M
authors.initials: M
authors.lastname: Modan
mesh_terms: D000368:Aged; D000673:Amputation, Traumatic / Q000503:physiopathology*; D001161:Arteriosclerosis / Q000503:physiopathology; D001341:Autonomic Nervous System / Q000503:physiopathology*; D001794:Blood Pressure / Q000502:physiology; D002395:Catecholamines / Q000097:blood; D004032:Diet; D015444:Exercise; D005951:Glucose Tolerance Test; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D007585:Jews; D007866:Leg; D008019:Life Style; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology; D011674:Pulse / Q000502:physiology; D012307:Risk Factors
chemical_list: D002395:Catecholamines; D008055:Lipids